ChartRow logo
Data provided bySource: Twelve Data
ELAN
$25.85-2.12%
as of close, Nov 17, 2026
☾ AH $25.85 -2.12%
PeersZTSVTRSRDYNBIXUTHRHLN
Share this page

ELAN — Elanco Animal Health Incorporated price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
Data provided bySource: Twelve Data
What would $1,000 invested in ELAN be worth today? →
ELAN returns: By year · By month · By week · Trailing

Price data

Price
$25.85
YTD price return
+14.23%
YTD total return
+14.23%
Market cap
12.9B
Enterprise value
16.5B
Shares outstanding
499.8M
52W low
$19.40
52W high
$27.98
From 52W high
-7.61%
From 52W low
+33.25%
52W range
75%$19.40–$27.98
Beta
1.67

Volume

Rel volume
0.74×
30D volume
5.2M
30D $ vol
124.7M

Insider trading

Insider net 1W
none
Insider net 1M
none
Insider net 3M
+$836K
Insider net 1Y
+$1.6M

Form 4 transactions by trade date, as filed; latest on file 2026-10-15.

Fundamentals

Sales (ttm)
5.1B
Sales/share
$10.30
EPS (ttm)
-$0.29
FCF (ttm)
408M
FCF/share
$0.82
Book value/share
$13.26
Net margin
-2.86%
ROE
-2.22%
ROA
-1.10%
Debt / equity
0.55×
Current ratio
2.09

Growth (CAGR, ttm) · 10Y

Sales
+12.14%+5.64%+1.46%+6.01%
FCF
+10.88%+51.18%+4.98%+25.21%
Shares
+0.60%+0.47%+1.11%n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share
+11.48%+5.14%+0.35%n/a
FCF/share
+10.22%+50.42%+3.77%n/a
Book value/share
-2.38%+2.13%-3.97%n/a
Price
+20.70%+29.79%-4.15%n/a
Total return
+20.70%+29.79%-4.15%n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
-87.9×
Fwd P/E
20.7×
P/S (ttm)
2.5×
P/B (mrq)
1.9×
P/FCF (ttm)
31.7×
EV/Sales (ttm)
3.2×
FCF yield (ttm)
3.16%
Buyback yield (realized, 1y)
-0.60%
Shareholder yield (realized, 1y)
-0.60%
Buyback yield (cash, ttm)
0.00%
Shareholder yield (cash, ttm)
0.00%

Vs own 10Y history

P/S
53rd
P/B
80th
P/FCF
59th

Bar = where today’s multiple sits in ELAN’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).

Performance · price returntotal return · as of 2026-11-17#

Data provided bySource: Twelve Data
1D
-2.12%
5D
-3.40%
1M
+9.77%
3M
+9.49%
YTD
+14.23%
1Y
+20.68%
5Y
-19.09%
1D
-2.12%
5D
-3.40%
1M
+9.77%
3M
+9.49%
YTD
+14.23%
1Y
+20.68%
5Y
-19.09%

Fundamentals#

Revenue

5Y CAGR +7.6%5Y CAGR +7.6%YoY +11.3%
$5.1B TTM$1.3B Q3 '26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

5Y n/m5Y n/mYoY n/m
−$147M TTM$18M Q3 '26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y n/m5Y n/mYoY n/m
−$0.29 TTM$0.04 Q3 '26
FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y n/m5Y n/mYoY +22.8%
$408M TTM$156M Q3 '26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM

TTM: operating cash flow $614M, capex −$206M

Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Q3 2026: operating cash flow $216M, capex −$60M

Shares (diluted)

5Y +12.5%5Y +12.5%YoY +2.0%
500.1M TTM506.5M Q3 '26
FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Gross profit

5Y CAGR +10.1%5Y CAGR +10.1%YoY +18.6%
$2.9B TTM$720M Q3 '26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Full ELAN financials →

About Elanco Animal Health#

Data provided bySource: Twelve Data

Elanco Animal Health Incorporated is an animal health company focused on developing, manufacturing, and marketing products for pets and farm animals. Its portfolio includes treatments and preventive solutions for parasitic control, dermatology, pain management, vaccines, and other therapeutic areas used in companion animals and livestock. The company serves veterinarians, pet owners, farmers, and producers across a wide range of species, including dogs, cats, cattle, poultry, swine, and sheep. Elanco Animal Health Incorporated also offers products used in food-animal health and production settings, supporting disease prevention and animal wellbeing in everyday care and commercial agriculture. Headquartered in Indianapolis, Indiana, Elanco Animal Health Incorporated operates as a diversified participant in the global animal health market, with a broad product mix spanning companion animal and farm animal care.

Indianapolis, IN·9,400 employees·Drug Manufacturers - Specialty & Generic·elanco.com·As of Oct 28, 2026

Recent filings#

All filings and insider trades →

ETFs holding ELAN#

19 of the 193 ETFs ChartRow carries live hold ELAN. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).

FundNameFiled weight
IJHiShares Core S&P Mid-Cap ETF0.3%
MDYSPDR S&P MidCap 400 ETF Trust0.3%
VBRVanguard Small-Cap Value ETF0.3%
VHTVanguard Health Care ETF0.2%
VBVanguard Small-Cap ETF0.1%
VXFVanguard Extended Market ETF0.1%
IWSiShares Russell Mid-Cap Value ETF0.1%
IWRiShares Russell Midcap ETF0.1%
TickerName1M1D
LLYEli Lilly and Company+12.61%-1.13%
JNJJohnson & Johnson+9.05%-1.36%
ABBVAbbVie Inc.+2.59%-0.59%
MRKMerck & Co. Inc.-1.77%-0.75%
UNHUnitedHealth Group Incorporated Common Stock (DE)-2.93%-5.42%
NVSNovartis AG+5.65%-0.67%
TMOThermo Fisher Scientific Inc.-0.47%-0.66%
AMGNAmgen Inc.+5.88%-0.95%